FDA says fungus confirmed in 1 of 3 lots of recalled steroid
(Reuters) - The Food and Drug Administration said on Thursday it has confirmed the presence of Exserohilum fungus in one of three lots of steroids used for pain injections from the pharmacy at the center of the widespread meningitis outbreak that has killed 19 people and infected more than 200 others.
Testing on the other two implicated lots of the steroid methylprednisolone acetate and other injectable drugs from the New England Compounding Center continues, the agency said.
The U.S. Centers for Disease Control and Prevention (CDC) said there was no firm evidence of infection in any patients beyond those exposed to the contaminated lots.
(Reporting by Bill Berkrot; Editing by Gerald E. McCormick)
- Israel rejects ceasefire plan, source says, as death toll nears 850 |
- White House aide says Republicans might try for Obama impeachment
- First Ebola victim in Sierra Leone capital on the run
- Bad weather seen as probable cause of Air Algerie crash
- EU edges to economic sanctions on Russia but narrows scope |